Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Entero Healthcare Solutions Limited – Financial Risk Summary** Entero faces critical compliance exposure with a maximum 10.0/10 compliance risk score and estimated remediation costs of ₹8–31 crore, primarily driven by unclear Extended Producer Responsibility (EPR) obligations and SEBI BRSR reporting gaps under the Core Expansion framework. The company's pharmaceutical distribution model generates material waste streams (medical packaging, expired products), yet reports zero Scope 1 and 2 emissions and unknown EPR applicability—a red flag for regulatory underreporting that could trigger SEBI enforcement action or operational disruptions. Water and GHG intensity risks (both 5.0/10) are moderate but amplified by the lack of disclosed baseline data; at India's carbon price of ₹600–900/tonne, unquantified emissions exposure could add ₹10–50 crore in future liability if carbon pricing mechanisms broaden. Priority: clarify EPR classification, validate emissions quantification across logistics networks, and align governance disclosures with BRSR Core requirements to mitigate delisting and enforcement risk.
Source: Entero Healthcare Solutions Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.